Novel Anti-Interleukin-1β Therapy Preserves Retinal Integrity: A Longitudinal Investigation Using OCT Imaging and Automated Retinal Segmentation in Small Rodents
Retinopathy of prematurity (ROP) is the leading cause of blindness in neonates. Inflammation, in particular interleukin-1β (IL-1β), is increased in early stages of the disorder, and contributes to inner and outer retinal vasoobliteration in the oxygen-induced retinopathy (OIR) model of ROP. A small...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_517d3ff6c4aa43ef846cb4aa5a9b4ca5 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Diane N. Sayah |e author |
700 | 1 | 0 | |a Diane N. Sayah |e author |
700 | 1 | 0 | |a Tianwei E. Zhou |e author |
700 | 1 | 0 | |a Tianwei E. Zhou |e author |
700 | 1 | 0 | |a Tianwei E. Zhou |e author |
700 | 1 | 0 | |a Samy Omri |e author |
700 | 1 | 0 | |a Samy Omri |e author |
700 | 1 | 0 | |a Javier Mazzaferri |e author |
700 | 1 | 0 | |a Christiane Quiniou |e author |
700 | 1 | 0 | |a Maëlle Wirth |e author |
700 | 1 | 0 | |a Maëlle Wirth |e author |
700 | 1 | 0 | |a France Côté |e author |
700 | 1 | 0 | |a France Côté |e author |
700 | 1 | 0 | |a Rabah Dabouz |e author |
700 | 1 | 0 | |a Rabah Dabouz |e author |
700 | 1 | 0 | |a Rabah Dabouz |e author |
700 | 1 | 0 | |a Michel Desjarlais |e author |
700 | 1 | 0 | |a Michel Desjarlais |e author |
700 | 1 | 0 | |a Santiago Costantino |e author |
700 | 1 | 0 | |a Santiago Costantino |e author |
700 | 1 | 0 | |a Sylvain Chemtob |e author |
700 | 1 | 0 | |a Sylvain Chemtob |e author |
700 | 1 | 0 | |a Sylvain Chemtob |e author |
245 | 0 | 0 | |a Novel Anti-Interleukin-1β Therapy Preserves Retinal Integrity: A Longitudinal Investigation Using OCT Imaging and Automated Retinal Segmentation in Small Rodents |
260 | |b Frontiers Media S.A., |c 2020-03-01T00:00:00Z. | ||
500 | |a 1663-9812 | ||
500 | |a 10.3389/fphar.2020.00296 | ||
520 | |a Retinopathy of prematurity (ROP) is the leading cause of blindness in neonates. Inflammation, in particular interleukin-1β (IL-1β), is increased in early stages of the disorder, and contributes to inner and outer retinal vasoobliteration in the oxygen-induced retinopathy (OIR) model of ROP. A small peptide antagonist of IL-1 receptor, composed of the amino acid sequence, rytvela, has been shown to exert beneficial anti-inflammatory effects without compromising immunovigilance-related NF-κB in reproductive tissues. We conducted a longitudinal study to determine the efficacy of "rytvela" in preserving the integrity of the retina in OIR model, using optical coherence tomography (OCT) which provides high-resolution cross-sectional imaging of ocular structures in vivo. Sprague-Dawley rats subjected to OIR and treated or not with "rytvela" were compared to IL-1 receptor antagonist (Kineret). OCT imaging and custom automated segmentation algorithm used to measure retinal thickness (RT) were obtained at P14 and P30; gold-standard immunohistochemistry (IHC) was used to confirm retinal anatomical changes. OCT revealed significant retinal thinning in untreated animals by P30, confirmed by IHC; these changes were coherently associated with increased apoptosis. Both rytvela and Kineret subsided apoptosis and preserved RT. As anticipated, Kineret diminished both SAPK/JNK and NF-κB axes, whereas rytvela selectively abated the former which resulted in preserved monocyte phagocytic function. Altogether, OCT imaging with automated segmentation is a reliable non-invasive approach to study longitudinally retinal pathology in small animal models of retinopathy. | ||
546 | |a EN | ||
690 | |a rytvela | ||
690 | |a kineret | ||
690 | |a anti-interleukin-1β | ||
690 | |a therapy | ||
690 | |a oxygen-induced retinopathy | ||
690 | |a retina | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Pharmacology, Vol 11 (2020) | |
787 | 0 | |n https://www.frontiersin.org/article/10.3389/fphar.2020.00296/full | |
787 | 0 | |n https://doaj.org/toc/1663-9812 | |
856 | 4 | 1 | |u https://doaj.org/article/517d3ff6c4aa43ef846cb4aa5a9b4ca5 |z Connect to this object online. |